WELL:PA:PA-HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF - Accumulating EUR (EUR)

ETF | Others |

Last Closing

USD 6.6677

Change

-0.08 (-1.14)%

Market Cap

N/A

Volume

103.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.36 (-0.79%)

USD 63.50B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-1.20 (-0.21%)

USD 12.35B
WRD:PA HSBC ETFs Public Limited Compa..

-0.01 (-0.01%)

USD 10.45B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+2.57 (+1.10%)

USD 8.60B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-0.80 (-0.16%)

USD 8.46B
WLD:PA Lyxor UCITS MSCI World D-EUR

-0.16 (-0.04%)

USD 7.00B
HHH:PA HSBC ETFs Public Limited Compa..

-0.13 (-0.22%)

USD 6.90B
LCWD:PA Multi Units Luxembourg - Lyxor..

N/A

USD 6.43B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-1.08 (-0.27%)

USD 5.51B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

-0.22 (-0.14%)

USD 4.88B

ETFs Containing WELL:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.74% 19% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.74% 19% F 47% F
Trailing 12 Months  
Capital Gain 13.67% 45% F 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.67% 45% F 62% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -1.08% 14% F 29% F
Dividend Return -1.08% 13% F 27% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 5.50% 86% B+ 93% A
Risk Adjusted Return -19.73% 12% F 24% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.